Detail akcie Viatris Rg-WI online

Business Summary: Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Viatris Inc revenues decreased 2% to $7.46B. Net loss totaled $212.5M vs. income of $488.7M. Revenues reflect Emerging Markets segment decrease of 7% to $1.2B, JANZ segment decrease of 7% to $667.4M, Developed markets segment decrease of 1% to $4.48B. Net loss reflects Emerging Markets segment income decrease of 13% to $512.2M, Developed markets segment income decrease of 4% to $1.92B.